Effects of romosozumab or denosumab treatment on the bone mineral density and disease activity for 6 months in patients with rheumatoid arthritis with severe osteoporosis: An open-label, randomized, pilot study

OBJECTIVES: To investigate effects of romosozumab treatment on disease activity and bone mineral density (BMD) in patients with rheumatoid arthritis (RA) and severe osteoporosis in comparison with effects of denosumab treatment. METHODS: A total of 50 women were enrolled in this study. The subjects...

Descripción completa

Detalles Bibliográficos
Autores principales: Mochizuki, Takeshi, Yano, Koichiro, Ikari, Katsunori, Okazaki, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Osteoporosis 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486617/
https://www.ncbi.nlm.nih.gov/pubmed/34632114
http://dx.doi.org/10.1016/j.afos.2021.08.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486617/
https://www.ncbi.nlm.nih.gov/pubmed/34632114
http://dx.doi.org/10.1016/j.afos.2021.08.001

Ejemplares similares